Skip to main content
Clinical Trials/CTRI/2017/12/011021
CTRI/2017/12/011021
Not yet recruiting
Phase 2

A Clinical Study to Evaluate the Safety and Efficacy of Brahmi Ghrita and Shankhapushpi Panak in the Management of Chittodvega with special reference to Generalized Anxiety Disorder.

ational Institute of Ayurveda0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Institute of Ayurveda
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient willing to sign the consent form.
  • 2\. Patients of either sex with age between 18 to 60 years.
  • 3\. Patient fulfilling the Diagnostic and Statistical Manual of Mental Disorder , Fourth Edition (DSM â?? IV).
  • 4\. Patient who score at least 14 on the Hamilton Anxiety Rating Scale (HARS â?? A) at baseline visit.

Exclusion Criteria

  • 1\.Chittodvega is due to direct physiological effect of a substance (e.g. A drug abuse, a medication ) or a general medical condition (e.g. Hyperthyroidism).
  • 2\.Occurence of Chittodvega exclusively during mood disorder, a psychotic disorder or a pervasive development disorder.
  • 3\.Patients having chronic diseases like Diabetes Mellitus, Ischemic Heart Disease, Dyslipidaemia, Hypertension, Malignancies, Chronic Renal Failure, any Endochrinological disorders etc. will be excluded.
  • 4\.Patients who have completed participation in any other clinical trial during the past six months.
  • 5\.Pregnant or lactating women.
  • 6\.Any other condition which the Investigator thinks may jeopardize the study.
  • 7\.Patients receiving Anxiolytic Drugs will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials